STOCK TITAN

Myomo (MYO): Rosalind Master Fund reports 9.18% stake and warrant blocker

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Myomo, Inc. (MYO) received an amended Schedule 13G/A from Rosalind Advisors, Inc., Rosalind Master Fund L.P. and related individuals, updating their beneficial ownership disclosure. Rosalind Master Fund L.P. is reported as beneficially owning 3,637,886 shares of common stock, representing approximately 9.18% of Myomo’s outstanding common stock, based on 39,607,854 shares outstanding as of July 31, 2026. The group also holds 3,763,258 additional shares issuable upon exercise of pre-funded warrants, but a 9.99% blocker provision prevents exercising these warrants to the extent it would push beneficial ownership above 9.99%. As a result, the reporting persons state they were not able to exercise any of the warrants at the event date. Rosalind Advisors acts as investment advisor to the fund, and Steven Salamon as portfolio manager; both may be deemed beneficial owners but expressly disclaim beneficial ownership of the shares.

Positive

  • None.

Negative

  • None.
Beneficially owned shares 3,637,886 shares Common stock beneficially owned by Rosalind Master Fund L.P.
Shares issuable from pre-funded warrants 3,763,258 shares Common stock issuable upon exercise of pre-funded warrants held by the group
Ownership percentage (common stock) 9.18% Approximate beneficial ownership of common stock by Rosalind Master Fund L.P.
Ownership cap (blocker) 9.99% Blocker provision limiting beneficial ownership from warrant exercises
Shares outstanding 39,607,854 shares Myomo common stock outstanding as of July 31, 2026
pre-funded warrants financial
"3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
beneficial ownership financial
"may have been deemed to have the beneficial ownership of 3,637,886 shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
blocker provision financial
"because they contain a blocker provision under which the holder"
shared voting power financial
"Shared Voting Power 7,401,144.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 7,401,144.00"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What percentage of Myomo (MYO) does Rosalind Master Fund currently report owning?

Rosalind Master Fund L.P. reports beneficial ownership of 3,637,886 Myomo common shares, or about 9.18% of the outstanding common stock, based on 39,607,854 shares outstanding as of July 31, 2026.

How many Myomo (MYO) shares could be issued to Rosalind from pre-funded warrants?

The filing states that 3,763,258 Myomo common shares are issuable upon the exercise of pre-funded warrants held by the reporting group, separate from the 3,637,886 currently held common shares.

What is the blocker provision affecting Rosalind’s Myomo (MYO) warrants?

The pre-funded warrants include a 9.99% blocker provision, preventing exercise to the extent it would result in beneficial ownership above 9.99% of Myomo’s common stock, so no warrants could be exercised at the event date.

Who are the reporting persons in this Myomo (MYO) Schedule 13G/A amendment?

The reporting persons are Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon, with Rosalind Advisors as investment advisor to the fund and Salamon as portfolio manager.

What voting and dispositive power does Rosalind report over Myomo (MYO) shares?

Each reporting person reports 0 sole voting and dispositive power and 3,637,886 shares of shared voting and shared dispositive power over Myomo common stock, reflecting the fund-held position.

Why do Rosalind Advisors and Steven Salamon disclaim beneficial ownership of Myomo (MYO) shares?

Although Rosalind Advisors advises the fund and Steven Salamon manages the portfolio and may be deemed beneficial owners, they explicitly disclaim beneficial ownership of the Myomo shares held by Rosalind Master Fund L.P.





62857J201

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth in Row 11 of the cover page for each Reporting Person is based upon 39,607,854 shares of the Issuer's common stock outstanding as of July 31,2026 in accordance with the 10Q filed by the issuer on August 5th, 2026. However, as more fully described in Item 4, the securities reported in rows (6), (8), and (9) show the number of shares of Common Stock that would be issuable upon exercise of such reported securities and do not give effect to blocker provisions. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows (6), (8), and (9). (6) 3,637,886 shares of Common Stock 3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 3,637,886 shares of Common Stock 3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 3,637,886 shares of Common Stock 3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 3,637,886 shares of Common Stock 3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:08/12/2026
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:08/12/2026
Aharon Gil
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:08/12/2026
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:08/12/2026